{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:10Z","timestamp":1791895210803,"version":"4.3.4"},"reference-count":49,"publisher":"Walter de Gruyter GmbH","issue":"7","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2026-0221_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Children and adolescents with Down syndrome (DS) are at increased risk of cardiometabolic impairment, but this vulnerability may not be adequately captured by body mass index (BMI) alone. This study aimed to characterize anthropometric, metabolic, and hepatic alterations in pediatric DS beyond conventional BMI-based assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0221_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 95 children and adolescents aged 5\u201318 years: 48 with DS and 47 controls. Anthropometric assessment included weight, height, waist circumference, BMI z-score, waist-to-height ratio (WHtR), and predicted body composition. Fasting blood samples were analyzed for glucose, insulin, homeostatic model assessment for insulin resistance (HOMA-IR), triglyceride-glucose (TyG) index, lipid profile, and liver enzymes. Between-group differences were assessed using age- and sex-adjusted analysis of covariance, while multivariate analyses identified the variables contributing most strongly to group discrimination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0221_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with controls, children with DS showed no significant difference in BMI z-score, but had higher WHtR and % fat mass and lower % fat-free mass (p&lt;0.05). They also exhibited a less favorable metabolic profile, with higher fasting glucose, HOMA-IR, and TyG index, lower HDL-cholesterol, higher triglycerides, and higher liver enzyme levels (p&lt;0.05). Multivariate analyses confirmed that liver enzymes, glycemic markers, HDL-cholesterol, and WHtR were the strongest contributors to group separation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0221_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children and adolescents with DS display an early high-risk cardiometabolic phenotype characterized by altered body composition, insulin resistance, dyslipidemia, and biochemical signs of hepatic involvement only partly reflected by BMI. These findings support broader metabolic surveillance in pediatric DS to improve early risk stratification and guide preventive interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2026-0221","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T08:57:51Z","timestamp":1780217871000},"page":"638-647","source":"Crossref","is-referenced-by-count":2,"title":["Early metabolic and hepatic alterations in children with Down syndrome: a hidden risk beyond BMI"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2137-5974","authenticated-orcid":false,"given":"Valeria","family":"Calcaterra","sequence":"first","affiliation":[{"name":"Pediatric and Adolescent Unit, Department of Internal Medicine , University of Pavia , Pavia , Italy"},{"name":"Pediatric Department , Buzzi Children\u2019s Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gatti","sequence":"additional","affiliation":[{"name":"Laboratory of Adapted Motor Activity (LAMA), Department of Public Health, Experimental Medicine and Forensic Science , University of Pavia , Pavia , Italy"},{"name":"Department of Public Health, Experimental and Forensic Medicine , University of Pavia , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Gazzarri","sequence":"additional","affiliation":[{"name":"Associazione Vivi Down Onlus , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"De Lorenzo","sequence":"additional","affiliation":[{"name":"Pediatric Department , Buzzi Children\u2019s Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Maggi","sequence":"additional","affiliation":[{"name":"Pediatric Department , Buzzi Children\u2019s Hospital , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Minardi","sequence":"additional","affiliation":[{"name":"Laboratory of Adapted Motor Activity (LAMA), Department of Public Health, Experimental Medicine and Forensic Science , University of Pavia , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria Carnevale","family":"Pellino","sequence":"additional","affiliation":[{"name":"Department of Education and Sport Sciences , Pegaso University , Naples , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Vandoni","sequence":"additional","affiliation":[{"name":"Laboratory of Adapted Motor Activity (LAMA), Department of Public Health, Experimental Medicine and Forensic Science , University of Pavia , Pavia , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[{"name":"Pediatric Department , Buzzi Children\u2019s Hospital , Milan , Italy"},{"name":"Department of Biomedical and Clinical Science , University of Milan , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026070716574681102_j_jpem-2026-0221_ref_001","doi-asserted-by":"crossref","unstructured":"Antonarakis, SE, Skotko, BG, Rafii, MS, Strydom, A, Pape, SE, Bianchi, DW, et al.. Down syndrome. Nat Rev Dis Primers 2020;6:9. https:\/\/doi.org\/10.1038\/s41572-019-0143-7.","DOI":"10.1038\/s41572-019-0143-7"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_002","doi-asserted-by":"crossref","unstructured":"Molinari, S, Fossati, C, Nicolosi, ML, Di Marco, S, Faraguna, MC, Limido, F, et al.. Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life. Front Endocrinol 2024;15:1348397. https:\/\/doi.org\/10.3389\/fendo.2024.1348397.","DOI":"10.3389\/fendo.2024.1348397"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_003","doi-asserted-by":"crossref","unstructured":"Binsaddiq, DW, Ibrahim, AI, Abualait, TS. Body composition and adiposity in children with Down syndrome compared to typically developing children: the association with their motor performance. Children 2025;12:1298. https:\/\/doi.org\/10.3390\/children12101298.","DOI":"10.3390\/children12101298"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_004","doi-asserted-by":"crossref","unstructured":"Hetman, M, Barg, E. Pediatric population with Down syndrome: obesity and the risk of cardiovascular disease and their assessment using omics techniques\u00a0\u2013 review. Biomedicines 2022;10:3219. https:\/\/doi.org\/10.3390\/biomedicines10123219.","DOI":"10.3390\/biomedicines10123219"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_005","doi-asserted-by":"crossref","unstructured":"Hatch-Stein, JA, Zemel, BS, Prasad, D, Kalkwarf, HJ, Pipan, M, Magge, SN, et al.. Body composition and BMI growth charts in children with Down syndrome. Pediatrics 2016;138:e20160541. https:\/\/doi.org\/10.1542\/peds.2016-0541.","DOI":"10.1542\/peds.2016-0541"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_006","doi-asserted-by":"crossref","unstructured":"Esparza Ocampo, K, Gast\u00e9lum Espinoza, W, Angulo Rojo, C, Guadr\u00f3n Llanos, A, Aguirre Villalobos, S, Camberos Barraza, J, et al.. Assessment of cardiometabolic risk factors in children with Down syndrome with normal weight: a comparative study against a non\u2013down syndrome cohort. J Intellect Disabil Res 2025;69:605\u201312. https:\/\/doi.org\/10.1111\/jir.13241.","DOI":"10.1111\/jir.13241"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_007","doi-asserted-by":"crossref","unstructured":"Magge, SN, Zemel, BS, Pipan, ME, Gidding, SS, Kelly, A. Cardiometabolic risk and body composition in youth with Down syndrome. Pediatrics 2019;144:e20190137. https:\/\/doi.org\/10.1542\/peds.2019-0137.","DOI":"10.1542\/peds.2019-0137"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_008","doi-asserted-by":"crossref","unstructured":"Moreau, M, Benhaddou, S, Dard, R, Tolu, S, Hamz\u00e9, R, Vialard, F, et al.. Metabolic diseases and Down syndrome: how are they linked together? Biomedicines 2021;9:221. https:\/\/doi.org\/10.3390\/biomedicines9020221.","DOI":"10.3390\/biomedicines9020221"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_009","doi-asserted-by":"crossref","unstructured":"Dierssen, M, Fructuoso, M, Mart\u00ednez De Lagr\u00e1n, M, Perluigi, M, Barone, E. Down syndrome is a metabolic disease: altered insulin signaling mediates peripheral and brain dysfunctions. Front Neurosci 2020;14:670. https:\/\/doi.org\/10.3389\/fnins.2020.00670.","DOI":"10.3389\/fnins.2020.00670"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_010","doi-asserted-by":"crossref","unstructured":"Goyal, NP, Xanthakos, S, Schwimmer, JB. Metabolic dysfunction-associated steatotic liver disease in children. Gut 2025;74:669\u201377. https:\/\/doi.org\/10.1136\/gutjnl-2023-331090.","DOI":"10.1136\/gutjnl-2023-331090"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_011","doi-asserted-by":"crossref","unstructured":"Miller, DM, McCauley, KF, Dunham\u2010Snary, KJ. Metabolic dysfunction\u2010associated steatotic liver disease (MASLD): mechanisms, clinical implications and therapeutic advances. Endocrino Diabet Metabol 2025;8:e70132. https:\/\/doi.org\/10.1002\/edm2.70132.","DOI":"10.1002\/edm2.70132"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_012","doi-asserted-by":"crossref","unstructured":"Panganiban, J, Kehar, M, Ibrahim, SH, Hartmann, P, Sood, S, Hassan, S, et al.. Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: an obesity medicine association (OMA) and expert joint perspective 2025. Obesity Pillars 2025;14:100164. https:\/\/doi.org\/10.1016\/j.obpill.2025.100164.","DOI":"10.1016\/j.obpill.2025.100164"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_013","doi-asserted-by":"crossref","unstructured":"Ng, NBH, Sng, AA, Huang, JG. Fighting the epidemic of pediatric metabolic dysfunction-associated steatotic liver disease: role of non-invasive diagnostics and early pharmacological intervention. World J Hepatol 2026;18:111211. https:\/\/doi.org\/10.4254\/wjh.v18.i1.111211.","DOI":"10.4254\/wjh.v18.i1.111211"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_014","doi-asserted-by":"crossref","unstructured":"Badakhshan, SN, Ghazizadeh, H, Mohammadi\u2010Bajgiran, M, Esmaily, H, Khorasani, MY, Bohn, MK, et al.. Age\u2010specific reference intervals for liver function tests in healthy neonates, infants, and young children in Iran. Clin Lab Anal 2023;37:e24995. https:\/\/doi.org\/10.1002\/jcla.24995.","DOI":"10.1002\/jcla.24995"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_015","doi-asserted-by":"crossref","unstructured":"Bizerea-Moga, TO, Moga, TV, Panic, ZS, Vukovic, R, M\u0103rginean, O, Chi\u015favu, L. Liver injury biomarkers in pediatric metabolic syndrome: key biochemical associations. Metabolites 2026;16:171. https:\/\/doi.org\/10.3390\/metabo16030171.","DOI":"10.3390\/metabo16030171"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_016","doi-asserted-by":"crossref","unstructured":"Egresi, A, Kozma, B, Kar\u00e1csony, M, R\u00f3nasz\u00e9ki, A, Werling, K, Csongr\u00e1dy, B, et al.. Cumulative effect of metabolic factors on hepatic steatosis. Diagnostics 2025;15:2406. https:\/\/doi.org\/10.3390\/diagnostics15182406.","DOI":"10.3390\/diagnostics15182406"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_017","doi-asserted-by":"crossref","unstructured":"Truong, XT, Lee, DH. Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications. Diabetes Metab J 2025;49:964\u201386. https:\/\/doi.org\/10.4093\/dmj.2025.0644.","DOI":"10.4093\/dmj.2025.0644"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_018","doi-asserted-by":"crossref","unstructured":"Gruben, N, Shiri-Sverdlov, R, Koonen, DPY, Hofker, MH. Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta Mol Basis Dis 2014;1842:2329\u201343. https:\/\/doi.org\/10.1016\/j.bbadis.2014.08.004.","DOI":"10.1016\/j.bbadis.2014.08.004"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_019","doi-asserted-by":"crossref","unstructured":"Karaceper, MD, Villegas, MJ, Sadh, S, Kawesa, S, Strain, J, Nair, A, et al.. Prevalence and risk factors of metabolic-associated fatty liver disease in children with Down syndrome at a tertiary care center. JCM 2025;14:3239. https:\/\/doi.org\/10.3390\/jcm14093239.","DOI":"10.3390\/jcm14093239"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_020","doi-asserted-by":"crossref","unstructured":"Dunn, LN, Niemeyer, BF, Eduthan, NP, Schade, KA, Waugh, KA, Brown, C, et al.. Altered hepatic metabolism in Down syndrome. Cell Rep 2026;45:116835. https:\/\/doi.org\/10.1016\/j.celrep.2025.116835.","DOI":"10.1016\/j.celrep.2025.116835"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_021","doi-asserted-by":"crossref","unstructured":"De Matteo, A, Vajro, P. Down syndrome and pediatric nonalcoholic fatty liver disease: a causal or casual relationship? J Pediatr 2017;189:11\u20133. https:\/\/doi.org\/10.1016\/j.jpeds.2017.07.011.","DOI":"10.1016\/j.jpeds.2017.07.011"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_022","doi-asserted-by":"crossref","unstructured":"Calcaterra, V, Ciriello, U, Medici, S, Pagani, V, Campoy, C, Labati, L, et al.. PODiaCarD: a prototype of a digital twin platform for the management of pediatric obesity and related cardiometabolic complications. Eur J Pediatr 2026;185:77. https:\/\/doi.org\/10.1007\/s00431-025-06708-2.","DOI":"10.1007\/s00431-025-06708-2"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_023","unstructured":"World Health Organization (WHO). Child growth standards [Internet]. [cited 2023 Jan 12]. Available from: https:\/\/www.who.int\/tools\/child-growth-standards."},{"key":"2026070716574681102_j_jpem-2026-0221_ref_024","doi-asserted-by":"crossref","unstructured":"Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Archives Dis Child 1969;44:291. https:\/\/doi.org\/10.1136\/adc.44.235.291.","DOI":"10.1136\/adc.44.235.291"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_025","doi-asserted-by":"crossref","unstructured":"Marshall, WA, Tanner, JM. Variations in the pattern of pubertal changes in boys. Archives Dis Child 1970;45:13\u201323. https:\/\/doi.org\/10.1136\/adc.45.239.13.","DOI":"10.1136\/adc.45.239.13"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_026","doi-asserted-by":"crossref","unstructured":"Vandoni, M, Gatti, A, Carnevale Pellino, V, Marin, L, Cavallo, C, Rossi, V, et al.. Exploring the link between metabolic syndrome risk and physical fitness in children with obesity: a cross-sectional study. Eur J Pediatr 2025;184:497. https:\/\/doi.org\/10.1007\/s00431-025-06339-7.","DOI":"10.1007\/s00431-025-06339-7"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_027","doi-asserted-by":"crossref","unstructured":"Calcaterra, V, De Giuseppe, R, Biino, G, Mantelli, M, Marchini, S, Bendotti, G, et al.. Relation between circulating oxidized-LDL and metabolic syndrome in children with obesity: the role of hypertriglyceridemic waist phenotype. J Pediatr Endocrinol Metabol 2017;30:1257\u201363. https:\/\/doi.org\/10.1515\/jpem-2017-0239.","DOI":"10.1515\/jpem-2017-0239"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_028","doi-asserted-by":"crossref","unstructured":"De, OM. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007;85:09. https:\/\/doi.org\/10.2471\/BLT.07.043497.","DOI":"10.2471\/BLT.07.043497"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_029","unstructured":"Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. [Accessed Apr 2026]."},{"key":"2026070716574681102_j_jpem-2026-0221_ref_030","doi-asserted-by":"crossref","unstructured":"Hudda, MT, Van Niekerk, E, Sedumedi, CM, Moeng\u2010Mahlangu, L, Whincup, PH, Reilly, JJ, et al.. Validation of anthropometric and bioelectrical impedance equations for the prediction of fat mass amongst South African children. Diabetes Obes Metab 2025;27:7275\u201384. https:\/\/doi.org\/10.1111\/dom.70129.","DOI":"10.1111\/dom.70129"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_031","doi-asserted-by":"crossref","unstructured":"Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u20139. https:\/\/doi.org\/10.1007\/BF00280883.","DOI":"10.1007\/BF00280883"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_032","doi-asserted-by":"crossref","unstructured":"Calcaterra, V, Gazzarri, A, De Silvestri, A, Madia, C, Baldassarre, P, Rossi, V, et al.. Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome. J Endocrinol Investig 2023;46:2319\u201325. https:\/\/doi.org\/10.1007\/s40618-023-02086-4.","DOI":"10.1007\/s40618-023-02086-4"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_033","doi-asserted-by":"crossref","unstructured":"Hocking, S, Samocha-Bonet, D, Milner, KL, Greenfield, JR, Chisholm, DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev 2013;34:463\u2013500. https:\/\/doi.org\/10.1210\/er.2012-1041.","DOI":"10.1210\/er.2012-1041"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_034","doi-asserted-by":"crossref","unstructured":"Liu, D, Lei, YL, Zhang, L, Wang, W, Shao, C, Zhou, Q, et al.. Associations of the fat-free mass index and the fat mass index with the risk of developing diabetes and prediabetes in US adults: a nationally representative cross-sectional study. Lipids Health Dis 2024;23:383. https:\/\/doi.org\/10.1186\/s12944-024-02370-z.","DOI":"10.1186\/s12944-024-02370-z"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_035","doi-asserted-by":"crossref","unstructured":"Oliver, CJ, Climstein, M, Rosic, N, Bosy\u2010Westphal, A, Tinsley, G, Myers, S. Fat\u2010free mass: friend or foe to metabolic health? J Cachexia Sarcopenia Muscle 2025;16:e13714. https:\/\/doi.org\/10.1002\/jcsm.13714.","DOI":"10.1002\/jcsm.13714"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_036","doi-asserted-by":"crossref","unstructured":"Pitchford, EA, Adkins, C, Hasson, RE, Hornyak, JE, Ulrich, DA. Association between physical activity and adiposity in adolescents with Down syndrome. Med Sci Sports Exerc 2018;50:667\u201374. https:\/\/doi.org\/10.1249\/MSS.0000000000001502.","DOI":"10.1249\/MSS.0000000000001502"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_037","doi-asserted-by":"crossref","unstructured":"Wyszy\u0144ska, J, Dere\u0144, K, Mazur, A, Mat\u0142osz, P. Anthropometric and body composition correlates of hypertension in children and adolescents with intellectual disabilities. JCM 2026;15:1058. https:\/\/doi.org\/10.3390\/jcm15031058.","DOI":"10.3390\/jcm15031058"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_038","doi-asserted-by":"crossref","unstructured":"Nevill, AM, Reuter, CP, Brand, C, Gaya, AR, Mota, J, Renner, JDP, et al.. BMI fails to reflect the developmental changes in body fatness between boys and girls during adolescence. IJERPH 2021;18:7833. https:\/\/doi.org\/10.3390\/ijerph18157833.","DOI":"10.3390\/ijerph18157833"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_039","doi-asserted-by":"crossref","unstructured":"Dimopoulos, K, Constantine, A, Clift, P, Condliffe, R, Moledina, S, Jansen, K, et al.. Cardiovascular complications of Down syndrome: scoping review and expert consensus. Circulation 2023;147:425\u201341. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059706.","DOI":"10.1161\/CIRCULATIONAHA.122.059706"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_040","doi-asserted-by":"crossref","unstructured":"Scoppola, V, Crudele, A, Mosca, A, Panera, N, Camillo, CD, Bock, C, et al.. Lifestyle intervention improves metabolic dysfunction-associated steatotic liver disease in children with Down syndrome. Nutrients 2025;17:2331. https:\/\/doi.org\/10.3390\/nu17142331.","DOI":"10.3390\/nu17142331"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_041","doi-asserted-by":"crossref","unstructured":"Valentini, F, Rocchi, G, Vespasiani-Gentilucci, U, Guarino, MPL, Altomare, A, Carotti, S. The origins of NAFLD: the potential implication of intrauterine life and early postnatal period. Cells 2022;11:562. https:\/\/doi.org\/10.3390\/cells11030562.","DOI":"10.3390\/cells11030562"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_042","doi-asserted-by":"crossref","unstructured":"Carnevale, PV, Calcaterra, V, Gatti, A, Cavallo, C, Balconi, S, Marin, L, et al.. Postural control in children with obesity: a cross-sectional comparison with normal-weight peers. Sport Sci Health 2026;22:55. https:\/\/doi.org\/10.1007\/s11332-025-01621-5.","DOI":"10.1007\/s11332-025-01621-5"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_043","doi-asserted-by":"crossref","unstructured":"Calcaterra, V, Verduci, E, De Silvestri, A, Magenes, VC, Siccardo, F, Schneider, L, et al.. Predictive ability of the estimate of fat mass to detect early-onset metabolic syndrome in prepubertal children with obesity. Children 2021;8:966. https:\/\/doi.org\/10.3390\/children8110966.","DOI":"10.3390\/children8110966"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_044","doi-asserted-by":"crossref","unstructured":"Calcaterra, V, Palombo, C, Malacarne, M, Pagani, M, Federico, G, Kozakova, M, et al.. Interaction between autonomic regulation, adiposity indexes and metabolic profile in children and adolescents with overweight and obesity. Children 2021;8:686. https:\/\/doi.org\/10.3390\/children8080686.","DOI":"10.3390\/children8080686"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_045","doi-asserted-by":"crossref","unstructured":"Vandoni, M, Lovecchio, N, Carnevale Pellino, V, Codella, R, Fabiano, V, Rossi, V, et al.. Self-reported physical fitness in children and adolescents with obesity: a cross-sectional analysis on the level of alignment with multiple adiposity indexes. Children 2021;8:476. https:\/\/doi.org\/10.3390\/children8060476.","DOI":"10.3390\/children8060476"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_046","doi-asserted-by":"crossref","unstructured":"Vandoni, M, Calcaterra, V, Carnevale Pellino, V, De Silvestri, A, Marin, L, Zuccotti, GV, et al.. \u201cFitness and fatness\u201d in children and adolescents: an Italian cross-sectional study. Children 2021;8:762. https:\/\/doi.org\/10.3390\/children8090762.","DOI":"10.3390\/children8090762"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_047","doi-asserted-by":"crossref","unstructured":"D\u2019Auria, E, Calcaterra, V, Gasparini, C, De Silvestri, A, Lamberti, R, Ghezzi, M, et al.. The impact of adiposity indices on lung function in children with respiratory allergic diseases. Obes Res Clin Pract 2022;16:314\u20138. https:\/\/doi.org\/10.1016\/j.orcp.2022.06.005.","DOI":"10.1016\/j.orcp.2022.06.005"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_048","doi-asserted-by":"crossref","unstructured":"Lischka, J, Pixner, T, M\u00f6rwald, K, Lauth, W, Furthner, D, Weghuber, D, et al.. Validation of fat mass metrics in pediatric obesity. Ann Nutr Metab 2024;28:1\u201310. https:\/\/doi.org\/10.1159\/000542029.","DOI":"10.1159\/000542029"},{"key":"2026070716574681102_j_jpem-2026-0221_ref_049","doi-asserted-by":"crossref","unstructured":"Licenziati, MR, Ballarin, G, Iannuzzo, G, Lonardo, MS, Di Vincenzo, O, Iannuzzi, A, et al.. A height-weight formula to measure body fat in childhood obesity. Ital J Pediatr 2022;48:106. https:\/\/doi.org\/10.1186\/s13052-022-01285-8.","DOI":"10.1186\/s13052-022-01285-8"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0221\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0221\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:03:28Z","timestamp":1783443808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0221\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,7,24]]}},"alternative-id":["10.1515\/jpem-2026-0221"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2026-0221","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}